Company
Headquarters: Nanjing, China
Employees: 548
CN¥2.48 Billion
CNY as of July 1, 2024
US$341.8 Million
Company | Market Cap (USD) |
---|---|
Abbott | $178.02 B |
Stryker Corporation | $126.48 B |
Boston Scientific Corporation | $112.32 B |
Medtronic | $98.95 B |
Edwards Lifesciences Corporation | $55.63 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Nanjing Vishee Medical Technology Co. Ltd has the following listings and related stock indices.
Stock: SSE: 688580 wb_incandescent